Thema: US50127T1097
KURA, US50127T1097
trading-6531134_1280.jpg - Foto: THN
Kura Oncology stock: UBS keeps Buy rating and USD 15 target
Kura Oncology stock remains under UBS coverage with a Buy rating. The company reported second-quarter revenue of USD 20.87 million.
ad-hoc-news.de, heute 20:19 Uhr
KURA, US50127T1097
UBS keeps USD 15 target for Kura Oncology stock
Kura reported USD 20.87 million revenue in second-quarter 2026. Kura Oncology stock costs EUR 8.71 on October 27, 2026 at 6:53 p.m. CEST.
ad-hoc-news.de, 27.10.26 18:59 Uhr
KURA, US50127T1097
Kura Oncology stock: Kura Oncology sets October 29 results ...
Q3 2026 revenue is forecast at USD 24.86 million. Kura Oncology stock costs EUR 8.79 on October 22, 2026 at 8:30 p.m. CEST.
ad-hoc-news.de, 22.10.26 20:34 Uhr
KURA, US50127T1097
UBS reaffirms USD 15 target for Kura Oncology stock
Q2 revenue reached USD 20.87 million. Kura Oncology stock costs EUR 8.85 on October 20, 2026, while Nasdaq showed USD 9.94 in the US session.
ad-hoc-news.de, 20.10.26 20:53 Uhr
KURA, US50127T1097
Kura Oncology stock has November 3 results date
Revenue hit USD 20.87 million on August 12, 2026. Kura Oncology stock fell 6.39 percent to USD 9.08 at the October 16 close on Nasdaq.
ad-hoc-news.de, 17.10.26 22:53 Uhr
KURA, US50127T1097
UBS keeps USD 15.00 target for Kura Oncology stock
Second-quarter revenue reached USD 20.87 million on August 12, 2026. Kura Oncology stock costs EUR 8.67 on October 15, 2026 at 10:09 p.m. CEST.
ad-hoc-news.de, 15.10.26 22:13 Uhr
KURA, US50127T1097
Kura Oncology stock heads into October 13 webcast focus ...
Kura Oncology stock posted Q2 revenue of USD 20.87 million and an adjusted loss of USD 0.77 per share. Analysts listed a USD 25.69 consensus target.
ad-hoc-news.de, 08.10.26 03:20 Uhr
KURA, US50127T1097
Kura Oncology stock reports a 128,250-share option grant ...
Kura Oncology stock reflects a 128,250-share employee option grant dated October 1, 2026. KOMZIFTI delivered USD 9.1 million in Q2 product revenue.
ad-hoc-news.de, 07.10.26 06:49 Uhr
KURA, US50127T1097
UBS reaffirms Buy for Kura Oncology stock at USD 15 target ...
